Feldan raises additional $1.7 mln in funding from Québec angels
Québec City-based biotechnology startup Feldan has secured $1.723 million in a fourth round of financing. The round adds to the $1.2 million in funds raised in March 2015. Members of Anges Québec, the Anges Québec Capital Fund, and other angel investors committed to the latest round, which was led by Xavier Harland, president of Gestion GFX. Feldan, whose technology is focused on cell therapy and regenerative medicine, will use the investment's proceeds to finalize its preclinical development of two products, and move them into the first clinical trial phase within two years.
5 October 2015•4 mins read
